心室頻拍(Ventricular Tachycardia):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Ventricular Tachycardia Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2660CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年4月28日
◆ページ数:81
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における心室頻拍(Ventricular Tachycardia) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 心室頻拍(Ventricular Tachycardia)
  - 当レポートの概要
・心室頻拍(Ventricular Tachycardia):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Ventricular Tachycardia Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2015″ provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Tachycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Ventricular Tachycardia 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials and Average Enrollment by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Unaccomplished Trials of Ventricular Tachycardia 27
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Ventricular Tachycardia Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Gilead Sciences, Inc. 35
Clinical Trial Overview of Gilead Sciences, Inc. 35
Baxter International Inc. 36
Clinical Trial Overview of Baxter International Inc. 36
Milestone Pharmaceuticals, Inc. 37
Clinical Trial Overview of Milestone Pharmaceuticals, Inc. 37
Jiangsu Furui Pharmaceuticals Co., Ltd 38
Clinical Trial Overview of Jiangsu Furui Pharmaceuticals Co., Ltd 38
Gilead Sciences 39
Clinical Trial Overview of Gilead Sciences 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Aop Orphan Pharmaceuticals AG 41
Clinical Trial Overview of Aop Orphan Pharmaceuticals AG 41
Actavis plc 42
Clinical Trial Overview of Actavis plc 42
Clinical Trial Overview of Top Institutes / Government 43
Institut de Recherches Internationales Servier 43
Clinical Trial Overview of Institut de Recherches Internationales Servier 43
Meshalkin Research Institute of Pathology of Circulation 44
Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation 44
Aalborg University Hospital 45
Clinical Trial Overview of Aalborg University Hospital 45
Assistance Publique – Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 46
Beaumont Health System 47
Clinical Trial Overview of Beaumont Health System 47
Capital District Health Authority, Canada 48
Clinical Trial Overview of Capital District Health Authority, Canada 48
Central Finland Hospital District 49
Clinical Trial Overview of Central Finland Hospital District 49
Department of Health, UK 50
Clinical Trial Overview of Department of Health, UK 50
Duke University 51
Clinical Trial Overview of Duke University 51
El Hospital General Universitario Gregorio Maranon 52
Clinical Trial Overview of El Hospital General Universitario Gregorio Maranon 52
Five Key Clinical Profiles 53
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81

List of Tables
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Region, 2015* 9
Ventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 10
Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 11
Ventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 12
Ventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 13
Ventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries, 2015* 14
Ventricular Tachycardia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 15
Ventricular Tachycardia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 16
Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 17
Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 18
Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 19
Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 20
Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase, 2015* 23
Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Ventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Ventricular Tachycardia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Ventricular Tachycardia Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Ventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 35
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 36
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Milestone Pharmaceuticals, Inc., 2015* 37
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jiangsu Furui Pharmaceuticals Co., Ltd, 2015* 38
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2015* 39
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 40
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aop Orphan Pharmaceuticals AG, 2015* 41
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 42
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2015* 43
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2015* 44
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg University Hospital, 2015* 45
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 46
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Beaumont Health System, 2015* 47
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 48
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Finland Hospital District, 2015* 49
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 50
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 51
Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by El Hospital General Universitario Gregorio Maranon, 2015* 52

List of Figures
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Region (%), 2015* 9
Ventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 10
Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 11
Ventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 12
Ventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 13
Ventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 14
Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 17
Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 18
Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 19
Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 20
Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23
Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24
Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Ventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Ventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Ventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 79

【レポートのキーワード】

心室頻拍(Ventricular Tachycardia)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心室頻拍(Ventricular Tachycardia):世界の治験レビュー(2015年上半期版)(Ventricular Tachycardia Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆